138 related articles for article (PubMed ID: 12679131)
1. Thrombospondin-1 inhibits in vitro megakaryocytopoiesis via CD36.
Yang M; Li K; Ng MH; Yuen PM; Fok TF; Li CK; Hogg PJ; Chong BH
Thromb Res; 2003 Jan; 109(1):47-54. PubMed ID: 12679131
[TBL] [Abstract][Full Text] [Related]
2. [Apoptosis of Megakaryocytic Leukemia Cell Line Meg-01 Induced by TSP-1 Via CD36/Caspase-3].
Kong HM; Su WQ; Luo Y; Ge H; Li L; Yang M; Jiang QL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):998-1004. PubMed ID: 35981353
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin-1 induces apoptosis in primary leukemia and cell lines mediated by CD36 and Caspase-3.
Li K; Yang M; Yuen PM; Chik KW; Li CK; Shing MM; Lam HK; Fok TF
Int J Mol Med; 2003 Dec; 12(6):995-1001. PubMed ID: 14612980
[TBL] [Abstract][Full Text] [Related]
4. The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEG rHuMGDF) on megakaryopoiesis in normal subjects and patients with myelodysplasia and acute myeloid leukaemia.
Adams JA; Liu Yin JA; Brereton ML; Briggs M; Burgess R; Hyde K
Br J Haematol; 1997 Oct; 99(1):139-46. PubMed ID: 9359514
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondin, a negative modulator of megakaryocytopoiesis.
Chen YZ; Incardona F; Legrand C; Momeux L; Caen J; Han ZC
J Lab Clin Med; 1997 Feb; 129(2):231-8. PubMed ID: 9016860
[TBL] [Abstract][Full Text] [Related]
6. Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36.
Yehualaeshet T; O'Connor R; Green-Johnson J; Mai S; Silverstein R; Murphy-Ullrich JE; Khalil N
Am J Pathol; 1999 Sep; 155(3):841-51. PubMed ID: 10487979
[TBL] [Abstract][Full Text] [Related]
7. CD36: a critical anti-angiogenic receptor.
Simantov R; Silverstein RL
Front Biosci; 2003 Sep; 8():s874-82. PubMed ID: 12957861
[TBL] [Abstract][Full Text] [Related]
8. Capillary sprout endothelial cells exhibit a CD36 low phenotype: regulation by shear stress and vascular endothelial growth factor-induced mechanism for attenuating anti-proliferative thrombospondin-1 signaling.
Anderson CR; Hastings NE; Blackman BR; Price RJ
Am J Pathol; 2008 Oct; 173(4):1220-8. PubMed ID: 18772338
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics.
Reiher FK; Volpert OV; Jimenez B; Crawford SE; Dinney CP; Henkin J; Haviv F; Bouck NP; Campbell SC
Int J Cancer; 2002 Apr; 98(5):682-9. PubMed ID: 11920636
[TBL] [Abstract][Full Text] [Related]
10. Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP/protein kinase A signaling cascade.
Roberts W; Magwenzi S; Aburima A; Naseem KM
Blood; 2010 Nov; 116(20):4297-306. PubMed ID: 20664056
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes.
Cursiefen C; Maruyama K; Bock F; Saban D; Sadrai Z; Lawler J; Dana R; Masli S
J Exp Med; 2011 May; 208(5):1083-92. PubMed ID: 21536744
[TBL] [Abstract][Full Text] [Related]
12. c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1.
Jiménez B; Volpert OV; Reiher F; Chang L; Muñoz A; Karin M; Bouck N
Oncogene; 2001 Jun; 20(26):3443-8. PubMed ID: 11423995
[TBL] [Abstract][Full Text] [Related]
13. CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells.
Dawson DW; Pearce SF; Zhong R; Silverstein RL; Frazier WA; Bouck NP
J Cell Biol; 1997 Aug; 138(3):707-17. PubMed ID: 9245797
[TBL] [Abstract][Full Text] [Related]
14. Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34 cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF).
Catani L; Gugliotta L; Campanini E; Mangianti S; Gibellini D; Baravelli S; Vianelli N; Lemoli RM; Tura S
Br J Haematol; 1998 Jan; 100(1):207-18. PubMed ID: 9450813
[TBL] [Abstract][Full Text] [Related]
15. In vivo effects of pegylated recombinant human megakaryocyte growth and development factor on hematopoiesis in normal mice.
Kabaya K; Akahori H; Shibuya K; Nitta Y; Ida M; Kusaka M; Kato T; Miyazaki H
Stem Cells; 1996 Nov; 14(6):651-60. PubMed ID: 8948023
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin-1 modulates VEGF signaling via CD36 by recruiting SHP-1 to VEGFR2 complex in microvascular endothelial cells.
Chu LY; Ramakrishnan DP; Silverstein RL
Blood; 2013 Sep; 122(10):1822-32. PubMed ID: 23896411
[TBL] [Abstract][Full Text] [Related]
17. Association of thrombospondin-1 with the actin cytoskeleton of human thrombin-activated platelets through an alphaIIbbeta3- or CD36-independent mechanism.
Saumet A; de Jesus N; Legrand C; Dubernard V
Biochem J; 2002 May; 363(Pt 3):473-82. PubMed ID: 11964147
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin-1 induces differential response in human corneal and conjunctival epithelial cells lines under in vitro inflammatory and apoptotic conditions.
Soriano-Romaní L; García-Posadas L; López-García A; Paraoan L; Diebold Y
Exp Eye Res; 2015 May; 134():1-14. PubMed ID: 25753839
[TBL] [Abstract][Full Text] [Related]
19. Thrombin-stimulated calcium mobilization is inhibited by thrombospondin via CD36.
Enenstein J; Gupta K; Vercellotti GM; Hebbel RP
Exp Cell Res; 1998 Feb; 238(2):465-71. PubMed ID: 9473355
[TBL] [Abstract][Full Text] [Related]
20. Opposite effects of thrombospondin-1 via CD36 and CD47 on homotypic aggregation of monocytic cells.
Yamauchi Y; Kuroki M; Imakiire T; Uno K; Abe H; Beppu R; Yamashita Y; Kuroki M; Shirakusa T
Matrix Biol; 2002 Aug; 21(5):441-8. PubMed ID: 12225809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
